Literature DB >> 30291508

Nimura lecture: why are you evaluating RV function in patients with pulmonary arterial hypertension?

Katsu Takenaka1.   

Abstract

LV is a pressure-generating pump which endures pressure overload, while RV is a flow-generating pump intolerant of pressure overload. Therefore, RV pump function (but not RV myocardial contractility) can easily fail in face of severe pulmonary arterial hypertension (PH) because of increased afterload. Available indexes of RV function are load dependent and incapable of accurately reflecting RV myocardial contractility. Animal RV in which myocardium is damaged extensively by either soldering iron or coronary occlusion can work well without causing systemic congestion or decreased SV. In clinical settings, evaluation of pre-treatment RV function in patients with PH has limited value in predicting prognosis. Furthermore, in virtually all patients with PH after successful lung transplantation, RV function has been reported to improve indicating that deteriorated RV function in patients with PH is due to an increase in RV afterload, but not to decreased RV myocardial contractility. In view of these facts, evaluation of RV function seems hardly useful in patients with PH.

Entities:  

Keywords:  Echocardiography; Lung transplantation; Pulmonary hypertension; RV function

Year:  2018        PMID: 30291508     DOI: 10.1007/s12574-018-0400-x

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  25 in total

1.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors:  T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

2.  Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.

Authors:  Jason Weatherald; Athénaïs Boucly; Denis Chemla; Laurent Savale; Mingkai Peng; Mitja Jevnikar; Xavier Jaïs; Yu Taniguchi; Caroline O'Connell; Florence Parent; Caroline Sattler; Philippe Hervé; Gérald Simonneau; David Montani; Marc Humbert; Yochai Adir; Olivier Sitbon
Journal:  Circulation       Date:  2017-10-25       Impact factor: 29.690

3.  Observations on the optimum time for operative intervention for aortic regurgitation. II. Serial echocardiographic evaluation of asymptomatic patients.

Authors:  W L Henry; R O Bonow; D R Rosing; S E Epstein
Journal:  Circulation       Date:  1980-03       Impact factor: 29.690

4.  The Fontan procedure: anatomy, complications, and manifestations of failure.

Authors:  Tyler B Fredenburg; Tiffanie R Johnson; Mervyn D Cohen
Journal:  Radiographics       Date:  2011 Mar-Apr       Impact factor: 5.333

5.  Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome.

Authors:  William E Hopkins; Alan D Waggoner
Journal:  Am J Cardiol       Date:  2002-01-01       Impact factor: 2.778

6.  Left and Right Ventricular Functional Dynamics Determined by Echocardiograms Before and After Lung Transplantation.

Authors:  Tomoko S Kato; Hilary F Armstrong; P Christian Schulze; Matthew Lippel; Atsushi Amano; Maryjane Farr; Matthew Bacchetta; Matthew N Bartels; Marco R Di Tullio; Shunichi Homma; Donna Mancini
Journal:  Am J Cardiol       Date:  2015-05-21       Impact factor: 2.778

7.  Pseudonormalized Doppler total ejection isovolume (Tei) index in patients with right ventricular acute myocardial infarction.

Authors:  Shiro Yoshifuku; Yutaka Otsuji; Kunitsugu Takasaki; Keiko Yuge; Akira Kisanuki; Koichi Toyonaga; Souki Lee; Takashi Murayama; Hitoshi Nakashima; Toshiro Kumanohoso; Shinichi Minagoe; Chuwa Tei
Journal:  Am J Cardiol       Date:  2003-03-01       Impact factor: 2.778

8.  Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.

Authors:  W E Hopkins; L L Ochoa; G W Richardson; E P Trulock
Journal:  J Heart Lung Transplant       Date:  1996-01       Impact factor: 10.247

9.  Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Journal:  Eur Heart J       Date:  2009-08-27       Impact factor: 29.983

Review 10.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga; Robert A Harrington; Jeffrey L Anderson; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Cindy L Grines; Mark A Hlatky; Alice K Jacobs; Sanjay Kaul; Robert C Lichtenberg; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Gerald M Pohost; Robert S Rosenson; Richard S Schofield; Samuel J Shubrooks; James H Stein; Cynthia M Tracy; Howard H Weitz; Deborah J Wesley
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.